Physician profile
Xiangping Li
NPI 1437360708
$1,528.19
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $43.52 · 2021: $42.83 · 2022: $876 · 2023: $338 · 2024: $76.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dixi Medical USA Corp | $823.57 | 2022 | |
| Abbvie INC. | $261.17 | 2022-2024 | |
| Neuropace, INC. | $150.77 | 2023 | |
| Amgen INC. | $81.91 | 2019-2023 | Repatha |
| Allergan, INC. | $49.66 | 2019 | |
| Neurocrine Biosciences, INC. | $28.46 | 2020 | |
| Merz North America, INC. | $26.74 | 2019 | |
| Csl Behring | $26.01 | 2021 | |
| Alexion Pharmaceuticals, INC. | $22.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.82 | 2021 | |
| Acadia Pharmaceuticals INC | $15.06 | 2020 | |
| Lilly USA, LLC | $13.39 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xiangping Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.